Vault-13

Artia Global Partners LP

MIAMI, FL · CIK 1937964 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2022 · limited partnership

As an employer

$526.0m reported value +18.6% vs Q1 2026
47positions
66.5%in top 10
7 new 11 added 3 reduced 8 sold out vs Q1 2026

Options: 0 call positions (— notional), 1 put positions ($15.8m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ABIVAX SA SPONSORED ADS ABVX ABVX 516,447 $68.8m13.08% 13.08% ReducedShares held: Q3 2025 225.5k, Q4 2025 600.7k, Q1 2026 600.7k, Q2 2026 516.4k -84.3k -84,300 -14.0%
2 INSMED INC COM PAR $.01 INSM INSM 589,052 $62.8m11.94% 11.94% ReducedShares held: Q3 2025 732.2k, Q4 2025 682.2k, Q1 2026 628.7k, Q2 2026 589.1k -39.7k -39,660 -6.3%
3 TREVI THERAPEUTICS INC COM TRVI TRVI 2,210,852 $41.2m7.84% 7.84% AddedShares held: Q3 2025 2.0m, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 2.2m +197.2k +197,250 9.8%
4 BRIGHTSPRING HEALTH SVCS INC COM BTSG BTSG 517,315 $36.1m6.86% 6.86% AddedShares held: Q3 2025 41.6k, Q4 2025 41.6k, Q1 2026 53.8k, Q2 2026 517.3k +463.5k +463,515 861.5%
5 REVOLUTION MEDICINES INC COM RVMD RVMD 185,390 $34.7m6.60% 6.60% AddedShares held: Q3 2025 104.2k, Q4 2025 104.2k, Q1 2026 125.0k, Q2 2026 185.4k +60.4k +60,400 48.3%
6 ARGENX SE SPONSORED ADR ARGX ARGX 29,739 $27.6m5.25% 5.25% UnchangedShares held: Q3 2025 78.3k, Q4 2025 64.7k, Q1 2026 29.7k, Q2 2026 29.7k
7 ALKERMES PLC SHS ALKS ALKS 448,964 $23.5m4.47% 4.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 449.0k
8 TRAVERE THERAPEUTICS INC COM TVTX TVTX 339,033 $19.3m3.66% 3.66% AddedShares held: Q3 2025 30.9k, Q4 2025 70.7k, Q1 2026 70.7k, Q2 2026 339.0k +268.3k +268,333 379.5%
9 ASTRAZENECA PLC ORD AZN AZN 98,376 $18.7m3.55% 3.55% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 95.4k, Q2 2026 98.4k +3.0k +3,000 3.1%
10 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 503,936 $17.1m3.25% 3.25% UnchangedShares held: Q3 2025 194.8k, Q4 2025 503.9k, Q1 2026 503.9k, Q2 2026 503.9k
11 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 162,990 $15.9m3.02% 3.02% UnchangedShares held: Q3 2025 108.7k, Q4 2025 205.1k, Q1 2026 163.0k, Q2 2026 163.0k
12 QUEST DIAGNOSTICS INC COM DGX DGX 65,122 $13.8m2.62% 2.62% AddedShares held: Q3 2025 81.7k, Q4 2025 40.8k, Q1 2026 40.8k, Q2 2026 65.1k +24.3k +24,305 59.5%
13 IONIS PHARMACEUTICALS INC COM IONS IONS 144,376 $11.4m2.18% 2.18% UnchangedShares held: Q3 2025 60.2k, Q4 2025 144.4k, Q1 2026 144.4k, Q2 2026 144.4k
14 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 767,098 $11.0m2.09% 2.09% UnchangedShares held: Q3 2025 628.4k, Q4 2025 767.1k, Q1 2026 767.1k, Q2 2026 767.1k
15 ALUMIS INC COM ALMS ALMS 278,546 $7.8m1.49% 1.49% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 325.0k, Q2 2026 278.5k -46.5k -46,500 -14.3%
16 VIKING THERAPEUTICS INC COM VKTX VKTX 180,731 $7.1m1.34% 1.34% UnchangedShares held: Q3 2025 146.2k, Q4 2025 719.4k, Q1 2026 180.7k, Q2 2026 180.7k
17 CELCUITY INC COM CELC CELC 59,316 $6.2m1.18% 1.18% AddedShares held: Q3 2025 0, Q4 2025 12.9k, Q1 2026 15.6k, Q2 2026 59.3k +43.7k +43,740 280.8%
18 CYTOKINETICS INC COM NEW CYTK CYTK 70,700 $6.0m1.14% 1.14% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 16.3k, Q2 2026 70.7k +54.4k +54,400 333.7%
19 MERCK & CO INC COM MRK MRK 46,700 $6.0m1.14% 1.14% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 46.7k, Q2 2026 46.7k
20 RAPPORT THERAPEUTICS INC COM RAPP RAPP 138,508 $5.8m1.10% 1.10% UnchangedShares held: Q3 2025 64.6k, Q4 2025 138.5k, Q1 2026 138.5k, Q2 2026 138.5k
21 JOHNSON & JOHNSON COM JNJ JNJ 22,600 $5.7m1.09% 1.09% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 22.6k, Q2 2026 22.6k
22 GUARDANT HEALTH INC COM GH GH 38,100 $5.7m1.09% 1.09% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 38.1k
23 ABSCI CORPORATION COM ABSI ABSI 464,444 $5.4m1.02% 1.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 464.4k
24 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 96,285 $5.3m1.01% 1.01% UnchangedShares held: Q3 2025 96.3k, Q4 2025 96.3k, Q1 2026 96.3k, Q2 2026 96.3k
25 SIONNA THERAPEUTICS INC COM SION SION 119,741 $5.3m1.00% 1.00% UnchangedShares held: Q3 2025 0, Q4 2025 119.7k, Q1 2026 119.7k, Q2 2026 119.7k
26 ASCENDIS PHARMA A/S ORD SHS ASND ASND 17,740 $4.7m0.90% 0.90% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 17.7k
27 ROIVANT SCIENCES LTD SHS ROIV ROIV 129,800 $4.6m0.87% 0.87% UnchangedShares held: Q3 2025 0, Q4 2025 129.8k, Q1 2026 129.8k, Q2 2026 129.8k
28 PALISADE BIO INC COM PALI PALI 1,992,367 $4.2m0.79% 0.79% UnchangedShares held: Q3 2025 0, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 2.0m
29 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 98,800 $4.0m0.76% 0.76% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 65.5k, Q2 2026 98.8k +33.3k +33,300 50.8%
30 BIOGEN INC COM BIIB BIIB 18,437 $4.0m0.76% 0.76% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 18.4k, Q2 2026 18.4k
31 XENON PHARMACEUTICALS INC COM XENE XENE 65,000 $3.9m0.75% 0.75% UnchangedShares held: Q3 2025 40.0k, Q4 2025 40.0k, Q1 2026 65.0k, Q2 2026 65.0k
32 BELITE BIO INC SPONSORED ADS BLTE BLTE 24,989 $3.8m0.73% 0.73% UnchangedShares held: Q3 2025 0, Q4 2025 18.0k, Q1 2026 25.0k, Q2 2026 25.0k
33 MINERALYS THERAPEUTICS INC COM MLYS MLYS 137,800 $3.7m0.71% 0.71% UnchangedShares held: Q3 2025 56.6k, Q4 2025 137.8k, Q1 2026 137.8k, Q2 2026 137.8k
34 PROKIDNEY CORP SHS CL A PROK PROK 1,806,939 $3.7m0.70% 0.70% UnchangedShares held: Q3 2025 0, Q4 2025 1.8m, Q1 2026 1.8m, Q2 2026 1.8m
35 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 72,100 $3.7m0.70% 0.70% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 20.9k, Q2 2026 72.1k +51.2k +51,200 245.0%
36 ORUKA THERAPEUTICS INC COM ORKA ORKA 33,400 $3.2m0.60% 0.60% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 33.4k
37 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 22,951 $2.8m0.53% 0.53% AddedShares held: Q3 2025 23.0k, Q4 2025 23.0k, Q1 2026 22.9k, Q2 2026 23.0k +20 +20 0.1%
38 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 5,000 $2.7m0.52% 0.52% UnchangedShares held: Q3 2025 5.0k, Q4 2025 5.0k, Q1 2026 5.0k, Q2 2026 5.0k
39 BRIGHT MINDS BIOSCIENCES INC COM NEW DRUG DRUG 38,407 $2.7m0.51% 0.51% UnchangedShares held: Q3 2025 0, Q4 2025 33.4k, Q1 2026 38.4k, Q2 2026 38.4k
40 KINIKSA PHARMACEUTICALS INTL ORD SHS CL A KNSA KNSA 29,200 $1.9m0.35% 0.35% UnchangedShares held: Q3 2025 29.2k, Q4 2025 29.2k, Q1 2026 29.2k, Q2 2026 29.2k
41 COMPASS THERAPEUTICS INC COM CMPX CMPX 383,200 $839.2k0.16% 0.16% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 383.2k
42 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 2,500 $837.0k0.16% 0.16% UnchangedShares held: Q3 2025 0, Q4 2025 2.5k, Q1 2026 2.5k, Q2 2026 2.5k
43 KODIAK SCIENCES INC COM KOD KOD 17,019 $663.1k0.13% 0.13% UnchangedShares held: Q3 2025 0, Q4 2025 17.0k, Q1 2026 17.0k, Q2 2026 17.0k
44 TENAX THERAPEUTICS INC COM NEW TENX TENX 42,080 $612.3k0.12% 0.12% UnchangedShares held: Q3 2025 0, Q4 2025 42.1k, Q1 2026 42.1k, Q2 2026 42.1k
45 NUVALENT INC COM COM 4,900 $605.1k0.12% 0.12% UnchangedShares held: Q3 2025 0, Q4 2025 8.1k, Q1 2026 4.9k, Q2 2026 4.9k
46 PEPGEN INC COM PEPG PEPG 205,324 $369.6k0.07% 0.07% UnchangedShares held: Q3 2025 0, Q4 2025 205.3k, Q1 2026 205.3k, Q2 2026 205.3k
47 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 4,000 $355.1k0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 4.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ELI LILLY & CO LLY LLY 38,220 $35.2m38.2k shares
TERNS PHARMACEUTICALS INC 104,800 $5.5m104.8k shares
ASCENDIS PHARMA A/S 17,740 $4.1m17.7k shares
ABBVIE INC ABBV ABBV 14,500 $3.2m14.5k shares
SOLENO THERAPEUTICS INC SLNO SLNO 68,490 $2.3m68.5k shares
BRIDGEBIO PHARMA INC BBIO BBIO 20,400 $1.5m20.4k shares
APOGEE THERAPEUTICS INC 5,886 $495.4k5.9k shares
AVALO THERAPEUTICS INC AVTX AVTX 28,970 $432.5k29.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Put XBIPut 100,000 $15.8m100.0k shares New